Astria Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.37 | -$0.37 | -$0.37 |
| Q2 2024 | 1 | -$0.42 | -$0.42 | -$0.42 |
| Q3 2024 | 4 | -$0.51 | -$0.30 | -$0.43 |
| Q1 2025 | 2 | -$0.44 | -$0.42 | -$0.44 |
| Q2 2025 | 1 | -$0.44 | -$0.44 | -$0.44 |
| Q3 2025 | 1 | -$0.44 | -$0.44 | -$0.44 |
| Q4 2025 | 1 | -$0.45 | -$0.45 | -$0.45 |
Astria Therapeutics, Inc. Earnings Date And Information
Astria Therapeutics, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.43 earnings per share for the quarter, missing analysts' consensus estimates of $-0.37 by $0.06. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Astria Therapeutics, Inc. has generated $-2 earnings per share over the last year ($-2.42 diluted earnings per share) and currently has a price-to-earnings ratio of -5.17. Astria Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based on prior year's report dates.
Astria Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.43 | $0 | $0 | ||
| 08/12/2024 | Q2 2024 | -$0.37 | -$0.43 | -0.06 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.35 | -$0.38 | -0.03 | $0 | |
| 03/04/2024 | Q4 2023 | -$0.69 | -$0.86 | -0.17 | $0 | |
| 11/13/2023 | Q3 2023 | -$0.51 | -$0.63 | -0.12 | $0 | |
| 08/07/2023 | Q2 2023 | -$0.50 | -$0.45 | 0.05 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.51 | -$0.32 | 0.19 | $0 | |
| 03/22/2023 | Q4 2022 | -$0.74 | -$0.66 | 0.08 | $0 | |
| 11/10/2022 | Q3 2022 | -$0.92 | -$0.87 | 0.05 | $0 | |
| 08/09/2022 | Q2 2022 | -$1.04 | -$0.86 | 0.18 | $0 | |
| 05/12/2022 | Q1 2022 | -$0.73 | -$1.17 | -0.44 | $0 | |
| 03/10/2022 | Q4 2021 | -$0.61 | -$0.74 | -0.13 | $0 | |
| 11/10/2021 | Q3 2021 | -$0.92 | -$0.61 | 0.31 | $0 | |
| 08/09/2021 | Q2 2021 | -$1.82 | -$1.25 | 0.57 | $0 | |
| 05/13/2021 | Q1 2021 | -$0.92 | -$45.60 | -44.68 | $0 | |
| 03/11/2021 | Q4 2020 | -$2.22 | -$2.41 | -0.19 | $0 | |
| 11/12/2020 | Q3 2020 | -$3.06 | -$3.36 | -0.3 | $0 | |
| 08/10/2020 | Q2 2020 | -$2.73 | -$3.18 | -0.45 | $0 | |
| 05/12/2020 | Q1 2020 | -$2.46 | -$3.00 | -0.54 | $0 | |
| 03/10/2020 | Q4 2019 | -$3.69 | -$2.49 | 1.2 | $0 |
Astria Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Astria Therapeutics, Inc.'s earnings date?
Astria Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based off last year's report dates.
-
How can I listen to Astria Therapeutics, Inc.'s earnings conference call?
The conference call for Astria Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Astria Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Astria Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Astria Therapeutics, Inc. generate each year?
Astria Therapeutics, Inc. (:ATXS) has a recorded net income of $0. Astria Therapeutics, Inc. has generated $-2.42 earnings per share over the last four quarters.
-
What is Astria Therapeutics, Inc.'s price-to-earnings ratio?
Astria Therapeutics, Inc. (:ATXS) has a price-to-earnings ratio of -5.17 and price/earnings-to-growth ratio is -0.57.
